Propanc Biopharma, Inc. (PPCB)
0.117
+0.01
(+4.74%)
USD |
NASDAQ |
Apr 02, 16:00
0.117
0.00 (0.00%)
After-Hours: 20:00
Propanc Biopharma EPS Diluted (Quarterly) : -0.3012 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lumos Diagnostics Holdings Ltd. | -- |
| Incannex Healthcare, Inc. | -0.5598 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.091M |
| Total Expenses (Quarterly) | 3.091M |
| Enterprise Value | 2.944M |
| Earnings Yield | -10.86K% |
| Normalized Earnings Yield | -10806.17 |